Welcome to the international HTA database

Showing [16381 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2021	Health Technology Wales (HTW)	Point-of-care ultrasound to diagnose gallstone disease
2021	National Institute for Health and Care Excellence (NICE)	Berotralstat for preventing recurrent attacks of hereditary angioedema. NICE technology appraisal guidance 738
2021	Ontario Health	Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2021	Scottish Medicines Consortium (SMC)	Secukinumab for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs)
2021	National Institute for Health and Care Excellence (NICE)	Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable. NICE technology appraisal guidance 739
2021	Scottish Medicines Consortium (SMC)	Brentuximab vedotin in combination with cyclophosphamide, doxorubicin and prednisone (CHP) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (sALCL)
2021	National Institute for Health and Care Excellence (NICE)	Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancer. NICE technology appraisal guidance 740
2021	Scottish Medicines Consortium (SMC)	Melatonin (Slenyto) for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (ASD) and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient
2021	Health Technology Wales (HTW)	Natriuretic peptides to rule-in and rule-out a diagnosis of acute heart failure in adults in the emergency department setting
2021	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	National spending and uptake of mobile radiology services in aged care facilities: an opportunity to improve access remains
2021	National Institute for Health and Care Excellence (NICE)	Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer. NICE technology appraisal guidance 741
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Ambulatory antibiotic prophylaxis for skin procedures
2021	National Institute for Health and Care Excellence (NICE)	Selpercatinib for treating advanced thyroid cancer with RET alterations. NICE technology appraisal guidance 742
2020	Technology Assessment at SickKids (TASK)	Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: prophylactic use of hydroxychloroquine (HCQ)
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: treatment with hydroxychloroquine (HCQ)
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: infectivity of patients who have recovered from disease
2020	Penn Medicine Center for Evidence-based Practice (CEP)	Cytokine adsorption for treatment of COVID-19 disease
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: decontamination and reprocessing of personal protective equipment (PPE)
2020	Penn Medicine Center for Evidence-based Practice (CEP)	Transmission of respiratory infections via showers
2020	NIHR Health Technology Assessment programme	Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
2020	Penn Medicine Center for Evidence-based Practice (CEP)	Remdesivir for treatment of COVID-19 disease
2020	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	Treatment of depression with transcranial magnetic stimulation using an H-coil (dTMS)
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: sedation-ventilation liberation of COVID+ patients
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: surgical masks and filtering face piece respirators (FFR) for health care providers
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: point-of-care (POC) testing
2020	Adelaide Health Technology Assessment (AHTA)	Genetic testing for diagnosis of inheritable cardiac rhythm disorders
2020	NIHR Health Technology Assessment programme	Best-practice prevention alone or with conventional or biological caries management for 3- to 7-year-olds: the FiCTION three-arm RCT
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: antibiotic management in ambulatory patients
2020	Adelaide Health Technology Assessment (AHTA)	Detection of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein antibody (MOG) antibodies for diagnosis of neuromyelitis optica (NMO) and myelin oligodendrocyte glycoprotein antibody-related demyelination (MARD)
2020	NIHR Health Technology Assessment programme	Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: temperature screening for healthcare personnel
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: criteria for discharging patients from inpatient care
2020	Norwegian Institute of Public Health (NIPH)	Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: high flow nasal cannula (HFNC)/non-invasive positive pressure ventilation (NIPPV) indications
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: proning considerations for patients on HFNC or BIPAP
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: criteria for advising home care patients to return to the hospital
2020	NIHR Health Services and Delivery Research programme	Stroke Sentinel Audit Programme: Investigating and Evaluating Stroke Therapy (SSNAPIEST)
2020	Norwegian Institute of Public Health (NIPH)	Intracoronary lithotripsy for the treatment of coronary artery disease: a health technology assessment
2020	Penn Medicine Center for Evidence-based Practice (CEP)	COVID-19: surge triage for suspected influenza-like illness
2020	NIHR Health Services and Delivery Research programme	An evaluation of a multifaceted intervention to reduce antimicrobial prescribing in care home residents [REducing Antimicrobials in Care Homes (REACH)]: a non-randomised feasibility study and process evaluation
2020	Norwegian Institute of Public Health (NIPH)	Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
2020	NIHR Health Services and Delivery Research programme	UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2020	Scottish Health Technologies Group (SHTG)	The Scottish asynchronous digital dermatology appointment service (DDAS)
2020	Health Information and Quality Authority (HIQA)	Evidence summary of the immune response following infection with SARS-CoV-2 or other human coronaviruses
2020	NIHR Health Technology Assessment programme	Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020	Health Information and Quality Authority (HIQA)	Factors influencing, and measures to improve, vaccination uptake: rapid evidence summary
2020	Canadian Agency for Drugs and Technologies in Health (CADTH)	Condition-level review on tuberculosis: repository of evidence and resources
2020	Health Information and Quality Authority (HIQA)	Face mask use by healthy people in the community to reduce SARS-CoV-2 transmission – protocol for rapid evidence update
2020	NIHR Health Services and Delivery Research programme	IMPlementation of A Relatives Toolkit (IMPART study): examining the critical success factors, barriers and facilitators to implementation of an online supported self-management intervention in the NHS
2020	NIHR Health Technology Assessment programme	Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
2020	Health Information and Quality Authority (HIQA)	Categorisation of ‘extremely medically vulnerable’ groups who may be at risk of severe illness from COVID-19: evidence review
2020	NIHR Health Technology Assessment programme	Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
2020	Health Information and Quality Authority (HIQA)	Analysis of spatial patterns of respiratory mortality in the HSE Mid-West region
2020	NIHR Health Technology Assessment programme	Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation
2020	Health Information and Quality Authority (HIQA)	Evidence summary on activities or settings associated with a higher risk of SARS-CoV-2 transmission
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Proton and carbon ion therapy - an update on indications
2020	NIHR Health Technology Assessment programme	Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2020	NIHR Health Technology Assessment programme	Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020	Malaysian Health Technology Assessment (MaHTAS)	Pre-dialysis education programme (PDEP)
2020	Malaysian Health Technology Assessment (MaHTAS)	Diagnostic approaches to solitary pulmonary nodule (SPN)
2020	Malaysian Health Technology Assessment (MaHTAS)	Cinacalcet for the treatment of secondary hyperparathyroidism in end stage renal failure and economic evaluation
2020	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Bedaquiline (new therapeutic indication: multi-drug-resistant pulmonary tuberculosis, 12 to < 18 years)]
2020	Malaysian Health Technology Assessment (MaHTAS)	Influenza vaccination for the elderly and economic evaluation
2020	Swiss Federal Office of Public Health (FOPH)	Olmesartan mono- and combination therapy in patients with essential hypertension
2020	Malaysian Health Technology Assessment (MaHTAS)	Intravenous iron for iron deficiency anaemia
2020	Swiss Federal Office of Public Health (FOPH)	Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitor therapy
2020	Malaysian Health Technology Assessment (MaHTAS)	Programmatic management of latent tuberculosis infection
2020	Malaysian Health Technology Assessment (MaHTAS)	Automatic guided vehicles (AGVs) for transportation of food and materials in hospitals
2020	NIHR Health Technology Assessment programme	Seizure first aid training for people with epilepsy attending emergency departments and their significant others: the SAFE intervention and feasibility RCT
2020	Malaysian Health Technology Assessment (MaHTAS)	Digital dental impression
2020	Malaysian Health Technology Assessment (MaHTAS)	Biocompatible peritoneal dialysis (PD) solution
2020	Swiss Federal Office of Public Health (FOPH)	Iron therapy for iron deficiency without anemia
2020	NIHR Health Technology Assessment programme	Unspecified living kidney donation in the UK: barriers to implementation and delivery
2020	Health Technology Wales (HTW)	Autologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Does headgear type used by the operating room staff affect postoperative surgical site infection rate?
2020	Health Technology Wales (HTW)	Pre-operative cardiopulmonary exercise testing for people in whom major abdominal surgery is planned
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Efficacy of transcutaneous vagus nerve stimulation as treatment for patients with depression
2020	Health Technology Wales (HTW)	Rapid antigen detecting tests for diagnosing group A streptococcal infections in the community pharmacy setting
2020	NIHR Health Technology Assessment programme	Understanding the health-care experiences of people with sickle cell disorder transitioning from paediatric to adult services: This Sickle Cell Life, a longitudinal qualitative study
2020	Health Technology Wales (HTW)	Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk
2020	Health Information and Quality Authority (HIQA)	Health Technology Assessment Scoping Report: Convalescent plasma for the treatment of COVID-19
2020	Health Technology Wales (HTW)	Point of care haemolysis detection in blood samples that may be deemed unfit for laboratory analysis
2020	Health Information and Quality Authority (HIQA)	Rapid health technology assessment (HTA) of alternatives to laboratory-based real-time RT-PCR to diagnose current infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Is there an association between the proportion of registered nurses (skill-mix) in the hospital health care team, and patient mortality or risk for falls or pressure ulcers?
2020	Health Information and Quality Authority (HIQA)	Evidence summary for the incubation period of COVID-19, or time to first positive test, in individuals exposed to SARS-CoV-2
2020	NIHR Health Technology Assessment programme	Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis
2020	Malaysian Health Technology Assessment (MaHTAS)	Acupuncture for headache, refractory neuralgia, Bell’s palsy, post-stroke, Guillain barre and transverse myelitis
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Safety and effectiveness of outpatient compared with inpatient induction of labour in singleton uncomplicated pregnancies
2020	Health Information and Quality Authority (HIQA)	Potential impact of different testing scenarios to reduce the duration of restriction of movement for close contacts of a COVID-19 case
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Effectiveness and safety of the left ventricular assist device (LVAD) as destination therapy in paediatric patients]
2020	Malaysian Health Technology Assessment (MaHTAS)	Laser fluorescence to detect tooth decay within the tooth structure
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Magnetic resonance image-guided radiotherapy in patients with cancer in thorax, abdomen, pelvis or head and neck
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Anti-inflammatory, antibiotic and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome)
2020	NIHR Health Technology Assessment programme	An app-, web- and social support-based weight loss intervention for adults with obesity: the HelpMeDoIt! feasibility RCT
2020	NIHR Health Services and Delivery Research programme	The effects of interoperable information technology networks on patient safety: a realist synthesis
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Effectiveness of laminar versus turbulent airflow in operating theaters, with regard to risk for postoperative surgical infections
2020	European Network for Health Technology Assessment (EUnetHTA)	Rolling Collaborative Review COVID-19 - Lopinavir + Ritonavir
2020	The Regional Health Technology Assessment Centre (HTA-centrum)	Update: Chlorhexidine wash prior to clean surgical procedures
2020	NIHR Health Services and Delivery Research programme	Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis